CKA — Nadh Oxidation/Nad Reduction, Alt/Sgpt Class I

FDA Device Classification

FDA product code CKA covers "Nadh Oxidation/Nad Reduction, Alt/Sgpt", a Class I medical device regulated under 21 CFR 862.1030. Submissions are reviewed by the Clinical Chemistry panel. At least 20 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
CKA
Device Class
Class I
Regulation Number
862.1030
Submission Type
510(k) Exempt
Review Panel
CH
Medical Specialty
Clinical Chemistry
Implant
No

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K120945Hitachi Chemical DiagnosticsHITACHI CLINICAL ANALYZER S TEST REAGENT CARTRIDGE ALT, HITACHI CLINICAL…Jun 7, 2013
K113382Alfa WassermannACE ALT REAGENTJul 19, 2012
K061020Dade BehringDIMENSION VISTA ALBUMIN, ALKALINE PHOSPHATASE, ASPARTATE AMINO TRANSFERASE…May 10, 2006
K020487CaresideCARESIDE ALTJun 4, 2002
K980028Trace AmericaALT (GPT) LIQUID STABLE 2 VIAL - INCORPORATING DYNAMIC STABILIZATION TECHNOLOGY…Feb 2, 1998
K973869Trace AmericaTRACE REAGENT LINE FOR THE COBAS MIRAJan 7, 1998
K974003Diagnostic ChemicalsALANINE AMINOTRANSFERASE-SL ASSAY CATALOGUE NUMBER 318-10, 318-30Dec 5, 1997
K971323Carolina Liquid ChemistriesALT OR SGPTApr 21, 1997
K965134Derma Media LabALT/SGPTFeb 18, 1997
K961123Trace ScientificALT INCORPORATING DSTApr 25, 1996
K952427Beckman InstrumentsCX ALANINE, CX ASPARTATE AMINOTRANSFERASE-PYRIDOXAL-5-PHOSPHATE, CX CREATINE…Sep 21, 1995
K952744Medical Diagnostic TechnologiesALANINE AMINOTRANSFERASE REAGENT SYSTEMAug 7, 1995
K951332Dade IntlPARAMAX ALANINE AMINOTRANSFERASE (GPT) REAGENTJun 19, 1995
K951818Hi ChemHICHEM ALT REAGENT KITMay 15, 1995
K944080Prisma SystemsALT QVETNov 22, 1994
K941314Stanbio LaboratorySTANBIO ALT/GPT (LUQUI-UV) TEST SETJul 20, 1994
K941497SolarcareSOLARCARE ALANINE AMINOTRANSFERASE MICRO-PLATE ASSAYMay 24, 1994
K941287Pointe Scientific, IncLIQUID ALT(SGPT) REAGENT SETMay 3, 1994
K935180Em Diagnostic SystemsALANINE AMINOTRANSFERASE (ALT) TESTJan 13, 1994
K930070IsolabHEMOCARD HEMOGLOBIN EApr 8, 1993

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.